IRLAB Therapeutics AB (publ) (IRLAB-A.ST)
IRLAB-A.ST Stock Price Chart
Explore IRLAB Therapeutics AB (publ) interactive price chart. Choose custom timeframes to analyze IRLAB-A.ST price movements and trends.
IRLAB-A.ST Company Profile
Discover essential business fundamentals and corporate details for IRLAB Therapeutics AB (publ) (IRLAB-A.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Feb 2017
Employees
31.00
Website
https://www.irlab.seCEO
Kristina Torfgard
Description
IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 and 1009 research programs for the treatment of neurodegenerative disorders and ageing; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is based in Gothenburg, Sweden.
IRLAB-A.ST Financial Timeline
Browse a chronological timeline of IRLAB Therapeutics AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 29 Oct 2025
Earnings released on 27 Aug 2025
Earnings released on 7 May 2025
EPS came in at -kr 0.65 , while revenue for the quarter reached kr 4.36M .
Earnings released on 14 Feb 2025
EPS came in at -kr 0.10 , while revenue for the quarter reached kr 42.82M .
Earnings released on 30 Oct 2024
EPS came in at -kr 0.61 , while revenue for the quarter reached kr 9.03M .
Earnings released on 10 Jul 2024
EPS came in at -kr 0.14 , while revenue for the quarter reached kr 42.78M .
Earnings released on 8 May 2024
EPS came in at -kr 0.75 .
Earnings released on 7 Feb 2024
EPS came in at -kr 0.67 , while revenue for the quarter reached -kr 1.19M , missing expectations by -110.84%.
Earnings released on 25 Oct 2023
EPS came in at -kr 0.74 .
Earnings released on 30 Aug 2023
EPS came in at -kr 0.87 , while revenue for the quarter reached kr 6.87M , missing expectations by -37.55%.
Earnings released on 10 May 2023
EPS came in at -kr 1.15 .
Earnings released on 23 Feb 2023
EPS came in at -kr 0.64 surpassing the estimated -kr 1.19 by +46.22%, while revenue for the quarter reached kr 12.18M , beating expectations by +10.74%.
Earnings released on 9 Nov 2022
EPS came in at -kr 0.46 surpassing the estimated -kr 1.09 by +57.80%, while revenue for the quarter reached kr 16.50M , beating expectations by +50.03%.
Earnings released on 24 Aug 2022
EPS came in at -kr 0.52 surpassing the estimated -kr 0.90 by +42.22%, while revenue for the quarter reached kr 23.41M , beating expectations by +112.82%.
Earnings released on 11 May 2022
EPS came in at -kr 0.56 surpassing the estimated -kr 0.65 by +13.85%, while revenue for the quarter reached kr 9.04M , missing expectations by -17.80%.
Earnings released on 23 Feb 2022
EPS came in at -kr 0.45 , while revenue for the quarter reached kr 12.14M .
Earnings released on 10 Nov 2021
EPS came in at kr 2.35 , while revenue for the quarter reached kr 195.64M .
Earnings released on 25 Aug 2021
EPS came in at -kr 0.51 .
Earnings released on 6 May 2021
EPS came in at -kr 0.39 .
Earnings released on 24 Feb 2021
EPS came in at -kr 0.40 .
Earnings released on 11 Nov 2020
EPS came in at -kr 0.55 , while revenue for the quarter reached -kr 29.00K .
IRLAB-A.ST Stock Performance
Access detailed IRLAB-A.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.